Platform Overview
All your data needs In one place.
Unlock the full potential of your data
Standardize & transform your precision medicine data
Streamline patient care
Rapid cohort creation & extensive interactive analysis (RStudio, Jupyter)
Powerful federated analytics, simplified & scalable
Precision drug targets & accelerated discovery
Industry-leading Nextflow-native pipeline acceleration
Streamlined end-to-end clinical & NGS analysis
The ultimate data security platform
Optimize collaborative R&D & costs
At Lifebit, we are committed to solving the most challenging problems in precision medicine, genomics and healthcare.Our mission is to create a world where access to biomedical data will never again be an obstacle to curing diseases.
Lifebit has agreed partnerships with two innovative population genomic initiatives in Mexico and Brazil to help diversify genomic research and reduce health inequality in Latin America.
Join Lifebit at ASHG 2023, November 1-5, in Washington, DC, for cutting-edge human genetics discussions and to celebrate ASHG's 75th anniversary. Be at the forefront of genetics research!
At Lifebit, we carve our own path. So can you. We're open source pioneers, innovators changing the world. Our driving mission: to revolutionise bioinformatics and biomedical data analysis forever.
In this new multi-year strategic partnership, Lifebit and Flatiron Health are working together to support vital research and enable scientific discoveries to accelerate cancer research
Access support online 24 hours a day, 7 days a week.
SOFTWARE
An end-to-end solution for large-scale clinico-genomic programs.
Unlock meaningful insights in real-time, so you can stay at the forefront of science innovation and research.
USE CASES
AREAS OF EXPERTISE
Lifebit's federated trusted research environment allows researchers to securely utilise sensitive clinical and genomic by bringing researcher’s analysis and computation to where the data resides
The velocity and volume of real world data means it is impossible for humans alone to gain ultimate value from this type of information. Lifebit REAL uses Artificial Intelligence for disease surveillance, drug identification and target discovery.
Lifebit's technology enables biobanks and population genomics initiatives to make their sensitive data findable, usable, and actionable.
We enable safe and secure access to data of some of the largest and most impactful biobanks and population genomics initiatives in the world.
Unlock the value of your large-scale health data with Lifebit’s Data Transformation Suite
Lifebit's mission is to create a world where access to biomedical data will never again be an obstacle to curing diseases. We provide genomics and health data software, empowering organisations across the globe to transform how they securely and safely leverage sensitive biomedical data.
Lifebit is committed committed to solving the most challenging problems in precision medicine, genomics and healthcare through our solutions to enabling safe and secure access to genomic and biomedical data.
Lifebit Publishes Data Federation Insights in ‘Frontiers in Genetics' providing a research perspective on recent progress in establishing federated data platforms
Industry Reflections on National-Level Trusted Research Environment Accreditation Policies
Read our latest article that explores the research challenges and opportunities which are opened up through data linkage
Lifebit CloudOS is an intelligent compute management platform for data analysis. It democratizes usage of the cloud for data analysis by taking care of all the computational aspects of deploying these analyses over cloud.
Overview
Solutions to accelerate your R&D by simplifying the management, analysis, and sharing of your precision medicine data.
Solutions to help streamlinepatient care & speed up insights.
Company Overview
Learn about our mission, latest news & events.
Resources Overview
Expand your knowledge with technical content on best practice& cutting-edge research.
We're pleased to share the recording of our recent webinar.
Event Date: 22nd May 2024